Sun Pharma beat Q3 estimates with a consolidated net profit of ₹3,369 crore, driven by steady domestic growth and innovative drug sales offsetting the decline in generic sales in the US.
​Sun Pharma beat Q3 estimates with a consolidated net profit of ₹3,369 crore, driven by steady domestic growth and innovative drug sales offsetting the decline in generic sales in the US. by Soban News (international And National News)
